O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

Clinical trial NCT00961220 · COMPLETED

Trial details

NCT number: NCT00961220
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7

Start date: 2010-02-01
Primary completion: 2012-04-08
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.